Skip to content
    Oost NL logo

    Oost NL

    Apeldoorn, NetherlandsFounded 1975

    Oost NL is the regional development agency for the eastern Netherlands provinces of Gelderland and Overijssel, commissioned by the Dutch Ministry of Economic Affairs. It provides venture capital, knowledge, and networks to innovative startups and SMEs in sectors such as food, health, tech, energy, and the circular economy.

    Deal activity decreased year-over-year (3 deals in the last 12 months vs 7 prior). Average disclosed round size is $26.1M (across 8 rounds with reported amounts).

    Find people at Oost NL on Goldilocks AI

    Portfolio

    33

    Fund Size

    —

    Top Stage

    Unknown

    Last 12 Mo

    3

    Team

    Annick Kronenburg

    Annick Kronenburg

    investment manager Health Specialisatie Investeren Sectoren Toegankelijke gezondheidszorg

    Bart van 't Ende

    Bart van 't Ende

    investment manager Tech Sectoren Sterke industrie Specialisatie Investeren

    Agnes Beldman

    Agnes Beldman

    adviseur Acquisitie & Marketing Specialisatie Internationaliseren

    Arjan van den Bogaard

    Arjan van den Bogaard

    controller Specialisatie Organisatie ondersteuning

    Aysenur Albayrak

    Aysenur Albayrak

    adviseur Marketing & Communicatie Specialisatie Organisatie ondersteuning

    FW

    Freek Welling

    Director Capital

    RJ

    Ralph Jansen

    Sr Investment Manager

    RT

    Robin Tjassens

    Impact Investor | Venture Capital

    PR

    Pieter Rhemrev

    OostNL Capital

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    42 investments
    CompanyRoundAmountDate
    OneThird logoOneThirdUnknown—Aug 2026
    BrillianceRGB logoBrillianceRGBSeed$6.5MApr 2026
    RIFT logoRIFTSeries B—Mar 2026
    TTibeay BiosciencesUnknown—Jan 2026
    Revyve logoRevyveSeries B—Sep 2025
    QuiX Quantum logoQuiX QuantumSeries A—Jul 2025
    PPlasmaCureSeries A—Jul 2025
    AAMT MedicalSeries B$25MApr 2025
    OneThird logoOneThirdSeries A—Jan 2025
    AAMT MedicalUnknown$25MJan 2025
    4Impact logo4ImpactUnknown—Nov 2024
    44Impact CapitalUnknown—Nov 2024
    Scope Biosciences logoScope BiosciencesUnknown—Oct 2023
    TTagworksSeries A$64MJun 2023
    Delta Life Science logoDelta Life ScienceSeries A—May 2023
    OneThird logoOneThirdSeed—Mar 2023
    LioniX International logoLioniX InternationalGrowth—Jan 2023
    Enzyre logoEnzyreSeries A—Nov 2022
    QuiX Quantum logoQuiX QuantumSeed—Jul 2022
    Xenikos logoXenikosSeries B$30MSep 2021
    ScreenPoint Medical logoScreenPoint MedicalSeries C$28MJul 2021
    GATT Technologies logoGATT TechnologiesSeries B—May 2020
    AAlveron PharmaSeed—Jan 2019
    MMimetasSeries B$20.5MApr 2018
    Axign logoAxignBridge$10M—
    Page 1 of 2

    Top Co-Investors

    Last updated: 20 October 2026